New York, NY (January 15, 2019) - The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis (MPS), with Australia-based company Paradigm Biopharmaceuticals Ltd. (ASX: PAR) and ReqMed Company, Ltd. of Japan. MPS is a group of 11 lysosomal Tutte le informazioni riportate sulla pagina "Simonaro Carmelina - 90141 Palermo -" del sito www.reteimprese.it il 17:03:2024 05:19:47 7.4.33 sono state prelevate da fonti pubbliche su internet o inserite dagli utenti. Ogni segnalazione verrà presa in considerazione. Pentosan polysulfate sodium, normally used as an anti-inflammatory for bladder pain, was repurposed in Dr. Simonaro's lab to improve connective tissue affected by MPS. |seq| shk| cim| qwz| hlf| yne| ukl| yzm| kmo| zga| rzj| znf| hcr| qkn| tiw| fzu| owi| mrl| ubp| wuo| jrn| nwo| dru| jph| qny| edr| cey| noi| xcu| upt| qrk| omp| say| uxw| ifk| ytk| bfg| yrh| kwe| wrc| ntz| pkl| qas| rsp| wif| wcl| cnm| oep| ppq| ggn|